Cryopreserved Oocytes Aid Patients with Poor Ovarian Response

JAMA Network

About The Study: This study of 67,000 freezing cycles among 47,000 patients reveals a distinct pattern in the utilization of cryopreserved oocytes among patients undergoing planned oocyte cryopreservation in the U.S. Despite the increase in number of patients pursuing oocyte cryopreservation, there is a notably low rate of return to utilize previously vitrified oocytes; notably, patients with poor ovarian response are more likely to return, although the time to return is similar to those with normal ovarian response.

Authors: Yuval Fouks, M.D., M.P.H., of Boston IVF-The Eugin Group in Waltham, Massachusetts, is the corresponding author.

To access the embargoed study: Visit our For The Media website at this link https://media.jamanetwork.com/

(doi:10.1001/jamanetworkopen.2023.49722)

/Public Release. This material from the originating organization/author(s) might be of the point-in-time nature, and edited for clarity, style and length. Mirage.News does not take institutional positions or sides, and all views, positions, and conclusions expressed herein are solely those of the author(s).View in full here.